Browse by Journal Title

Article

Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas.
Staudacher, J.J. and Arnold, A. and Kühl, A.A. and Pötzsch, M. and Daum, S. and Winterfeld, M. and Berg, E. and Hummel, M. and Rau, B. and Stein, U. and Treese, C.
BMC Cancer 22 (1): 953. 5 September 2022

Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations.
Nimptsch, K. and Aleksandrova, K. and Fedirko, V. and Jenab, M. and Gunter, M.J. and Siersema, P.D. and Wu, K. and Katzke, V. and Kaaks, R. and Panico, S. and Palli, D. and May, A.M. and Sieri, S. and Bueno-de-Mesquita, B. and Standahl, K. and Sánchez, M.J. and Perez-Cornago, A. and Olsen, A. and Tjønneland, A. and Bonet, C.B. and Dahm, C.C. and Chirlaque, M.D. and Fiano, V. and Tumino, R. and Barricarte Gurrea, A. and Boutron-Ruault, M.C. and Menegaux, F. and Severi, G. and van Guelpen, B. and Lee, Y.A. and Pischon, T.
BMC Cancer 22 (1): 695. 24 June 2022

FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
Raschzok, N. and Stintzing, S. and Heinemann, V. and Rauch, G. and Ricke, J. and Guckenberger, M. and Kurreck, A. and Alig, A.H.S. and Stahler, A. and Bullinger, L. and Schmelzle, M. and Schöning, W. and Lurje, G. and Krenzien, F. and Haase, O. and Rau, B. and Gebauer, B. and Sauer, I.M. and Pratschke, J. and Modest, D.P.
BMC Cancer 22 (1): 359. 2 April 2022

Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin.
Gillissen, B. and Richter, A. and Essmann, F. and Kemmner, W.
BMC Cancer 21 (1): 971. 30 August 2021

Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model.
Akpa, C.A. and Kleo, K. and Oker, E. and Tomaszewski, N. and Messerschmidt, C. and López, C. and Wagener, R. and Oehl-Huber, K. and Dettmer, K. and Schoeler, A. and Lenze, D. and Oefner, P.J. and Beule, D. and Siebert, R. and Capper, D. and Dimitrova, L. and Hummel, M.
BMC Cancer 20 (1): 427. 14 May 2020

Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience.
Striefler, J.K. and Brandes, F. and Baur, A. and Pfitzner, B.M. and Kaul, D. and Rau, D. and Dörr, A. and Schmiester, M. and Koulaxouzidis, G. and Bullinger, L. and Märdian, S. and Flörcken, A.
BMC Cancer 20 (1): 68. 29 January 2020

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing.
Andersch, L. and Radke, J. and Klaus, A. and Schwiebert, S. and Winkler, A. and Schumann, E. and Grunewald, L. and Zirngibl, F. and Flemmig, C. and Jensen, M.C. and Rossig, C. and Joussen, A. and Henssen, A. and Eggert, A. and Schulte, J.H. and Künkele, A.
BMC Cancer 19 (1): 895. 9 September 2019

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
Burock, S. and Daum, S. and Keilholz, U. and Neumann, K. and Walther, W. and Stein, U.
BMC Cancer 18 (1): 297. 15 March 2018

Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
Pahle, J. and Menzel, L. and Niesler, N. and Kobelt, D. and Aumann, J. and Rivera, M. and Walther, W.
BMC Cancer 17 (1): 129. 13 February 2017

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
Koelzer, V.H. and Herrmann, P. and Zlobec, I. and Karamitopoulou, E. and Lugli, A. and Stein, U.
BMC Cancer 15 (1): 160. 21 March 2015

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
Berenstein, R. and Blau, O. and Nogai, A. and Waechter, M. and Slonova, E. and Schmidt-Hieber, M. and Kunitz, A. and Pezzutto, A. and Doerken, B. and Blau, I.W.
BMC Cancer 15 (1): 68. 18 February 2015

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial.
Pelzer, U. and Hilbig, A. and Stieler, J.M. and Bahra, M. and Sinn, M. and Gebauer, B. and Doerken, B. and Riess, H.
BMC Cancer 14 (1): 204. 19 March 2014

Concerted down-regulation of immune-system related genes predicts metastasis in colorectal carcinoma.
Fehlker, M. and Huska, M.R. and Joens, T. and Andrade-Navarro, M.A. and Kemmner, W.
BMC Cancer 14 (1): 64. 5 February 2014

Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator.
Vlaicu, P. and Mertins, P. and Mayr, T. and Widschwendter, P. and Ataseven, B. and Högel, B. and Eiermann, W. and Knyazev, P. and Ullrich, A.
BMC Cancer 13 : 197. 18 April 2013

Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
Wang, Q. and Ma, C. and Kemmner, W.
BMC Cancer 13 (1): 137. 21 March 2013

MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells.
Gregersen, L.H. and Jacobsen, A. and Frankel, L.B. and Wen, J. and Krogh, A. and Lund, A.H.
BMC Cancer 12 : 232. 12 June 2012

SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
Mardin, W.A. and Petrov, K.O. and Enns, A. and Senninger, N. and Haier, J. and Mees, S.T.
BMC Cancer 10 : 549. 12 October 2010

Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study.
Pelzer, U. and Arnold, D. and Govercin, M. and Stieler, J. and Doerken, B. and Riess, H. and Oettle, H.
BMC Cancer 10 (1): 86. 9 March 2010

Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.
Siegel, R. and Burock, S. and Wernecke, K.D. and Kretzschmar, A. and Dietel, M. and Loy, V. and Koswig, S. and Budach, V. and Schlag, P.M.
BMC Cancer 9 (1): 50. 6 February 2009

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy.
Riess, H. and Pelzer, U. and Hilbig, A. and Stieler, J. and Opitz, B. and Scholten, T. and Kauschat-Bruning, D. and Bramlage, P. and Doerken, B. and Oettle, H.
BMC Cancer 8 (1): 361. 5 December 2008

Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.
Korff, S. and Woerner, S.M. and Yuan, Y.P. and Bork, P. and von Knebel Doeberitz, M. and Gebert, J.
BMC Cancer 8 (1): 329. 10 November 2008

Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study.
Hildebrandt, B. and Mueller, C. and Pezzutto, A. and Daniel, P.T. and Doerken, B. and Scholz, C.
BMC Cancer 7 : 185. 3 October 2007

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A phase II-study and historical comparison with the surgical approach.
Hildebrandt, B. and Pech, M. and Nicolaou, A. and Langrehr, J.M. and Kurcz, J. and Bartels, B. and Miersch, A. and Felix, R. and Neuhaus, P. and Riess, H. and Doerken, B. and Ricke, J.
BMC Cancer 7 : 69. 24 April 2007

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.
Sturm, I. and Rau, B. and Schlag, P.M. and Wust, P. and Hildebrandt, B. and Riess, H. and Hauptmann, S. and Doerken, B. and Daniel, P.T.
BMC Cancer 6 : 124. 10 May 2006

Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl, D. and Kammerer, B. and Handrick, R. and Eldh, T. and Gruber, C. and Cordes, N. and Daniel, P.T. and Plasswilm, L. and Bamberg, M. and Belka, C. and Jendrossek, V.
BMC Cancer 6 : 14. 17 January 2006

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Sturm, I. and Bosanquet, A.G. and Hummel, M. and Doerken, B. and Daniel, P.T.
BMC Cancer 5 : 105. 18 August 2005

Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis.
Marini, P. and Schmid, A. and Jendrossek, V. and Faltin, H. and Daniel, P.T. and Budach, W. and Belka, C.
BMC Cancer 5 : 5. 14 January 2005

Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Reimer, T.A. and Anagnostopoulos, I. and Erdmann, B. and Lehmann, I. and Stein, H. and Daniel, P. and Doerken, B. and Rehm, A.
BMC Cancer 5 (1): 47. 1 January 2005